--- title: "Alamar Biosciences (ALMR) news: IPO" url: "https://aibio.space/companies/alamar-biosciences/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "ALMR IPO news: Alamar Biosciences prices IPO of 11,250,000 shares at $17.00 each. Alamar Biosciences, Inc. (NASDAQ: ALMR), United States." --- ALMR Alamar Biosciences, Inc. NASDAQ · United States # Alamar Biosciences (ALMR) news ALMR IPO news Financings · 2026-04-17 ## [Alamar Biosciences prices IPO of 11,250,000 shares at $17.00 each](https://aibio.space/news/alamar-biosciences-prices-ipo-11-250-000-shares-17-00-each/) Alamar priced 11,250,000 shares at $17.00 each, and the underwriters later exercised their option in full, bringing gross proceeds to about $219.9 million. ## Latest Alamar Biosciences news 1. 2026-03-27 Financings [Alamar Biosciences files for IPO, plans Nasdaq listing as ALMR](https://aibio.space/news/alamar-biosciences-files-ipo-plans-nasdaq-listing-almr/) Alamar Biosciences filed an S-1 on March 27, 2026, reporting a 2025 net loss of $29.8 million on revenue of $74.2 million. The cover leaves the share count and price range blank. ## Alamar Biosciences at a glance - **Ticker**: ALMR - **Listing**: NASDAQ - **Country**: United States ### Related companies - [TuHURA Biosciences](https://aibio.space/companies/tuhura-biosciences/) NASDAQ: HURA - [Lakewood-Amedex Biotherapeutics](https://aibio.space/companies/lakewood-amedex-biotherapeutics/) NASDAQ: LABT - [PureTech Health](https://aibio.space/companies/puretech-health/) LSE: PRTC - [Intellia Therapeutics](https://aibio.space/companies/intellia-therapeutics/) NASDAQ: NTLA - [Pliant Therapeutics](https://aibio.space/companies/pliant-therapeutics/) NASDAQ: PLRX - [REBUS HLDGS INC.](https://aibio.space/companies/rebus-hldgs/) OTC: RBSH - [Imunon](https://aibio.space/companies/imunon/) NASDAQ: IMNN - [Celldex Therapeutics](https://aibio.space/companies/celldex-therapeutics/) NASDAQ: CLDX ### Also on NASDAQ - [Sagimet Biosciences](https://aibio.space/companies/sagimet-biosciences/) SGMT - [Gossamer Bio](https://aibio.space/companies/gossamer-bio/) GOSS - [TuHURA Biosciences](https://aibio.space/companies/tuhura-biosciences/) HURA - [SI-BONE](https://aibio.space/companies/si-bone/) SIBN - [UFP TECHNOLOGIES INC](https://aibio.space/companies/ufp-technologies/) UFPT - [Legend Biotech](https://aibio.space/companies/legend-biotech/) LEGN ## Questions about Alamar Biosciences When did Alamar Biosciences go public? Our latest story on this, dated Apr 17, 2026: "Alamar Biosciences prices IPO of 11,250,000 shares at $17.00 each". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/alamar-biosciences-prices-ipo-11-250-000-shares-17-00-each/). What is the ticker symbol of Alamar Biosciences? Alamar Biosciences, Inc. trades under the ticker ALMR on NASDAQ. Where is Alamar Biosciences listed? Alamar Biosciences, Inc. is listed on NASDAQ. What is the SEC CIK of Alamar Biosciences? The SEC Central Index Key (CIK) for Alamar Biosciences, Inc. is 2104204. Its filings are on SEC EDGAR. How many shares does Alamar Biosciences have outstanding? 69,392,766 shares as of 2026-07-31, per the cover page of its 10-Q filed 2026-08-11. Which country or territory is Alamar Biosciences listed under? Our directory records Alamar Biosciences, Inc. under United States. What does Alamar Biosciences do? Our directory classifies Alamar Biosciences, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Alamar Biosciences? The ISIN recorded for Alamar Biosciences, Inc. is US0109111056. Does aibio.space cover Alamar Biosciences? aibio.space lists Alamar Biosciences, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Alamar Biosciences incorporated? SEC records list its state or country of incorporation as DE. What is the latest Alamar Biosciences (ALMR) stock news? Our latest story on Alamar Biosciences, dated Apr 17, 2026: "Alamar Biosciences prices IPO of 11,250,000 shares at $17.00 each". Alamar priced 11,250,000 shares at $17.00 each, and the underwriters later exercised their option in full, bringing gross proceeds to about $219.9 million. [Source](https://aibio.space/news/alamar-biosciences-prices-ipo-11-250-000-shares-17-00-each/). What is Alamar Biosciences's latest stock offering or financing news? Our latest financing story, dated Apr 17, 2026: "Alamar Biosciences prices IPO of 11,250,000 shares at $17.00 each". Alamar priced 11,250,000 shares at $17.00 each, and the underwriters later exercised their option in full, bringing gross proceeds to about $219.9 million. [Source](https://aibio.space/news/alamar-biosciences-prices-ipo-11-250-000-shares-17-00-each/). Who were the underwriters or placement agents on Alamar Biosciences's offering? From our story: The cover names J.P. Morgan, BofA Securities, TD Cowen, Leerink Partners and Stifel as underwriters and does not say which of them lead the deal. [Source](https://aibio.space/news/alamar-biosciences-prices-ipo-11-250-000-shares-17-00-each/). Is Alamar Biosciences a smaller reporting company? SEC records list Alamar Biosciences, Inc.'s filer category as:
Emerging growth company. Where is Alamar Biosciences headquartered? SEC records list its business address as 47071 BAYSIDE PARKWAY, FREMONT, CA, 94538. ## Investor discussion: Alamar Biosciences Members talk about Alamar Biosciences (ALMR). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Alamar Biosciences, newest first. Each line links the filing it comes from. 1. 2026-04-17 Financings Reported a financing. SEC Form 424B4. [Source](https://www.sec.gov/Archives/edgar/data/2104204/000119312526161647/d39680d424b4.htm) 2. 2026-03-27 Financings Filed a registration statement for a share offering. SEC Form S-1. [Source](https://www.sec.gov/Archives/edgar/data/2104204/000119312526129039/d39680ds1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:ALMR on TradingView](https://www.tradingview.com/symbols/NASDAQ-ALMR/). ## SEC filings and registration - **SEC name**: Alamar Biosciences, Inc. - **CIK**: 2104204 - **Industry (SIC)**: Laboratory Analytical Instruments (3826) - **US tickers**: ALMR (Nasdaq) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**:
Emerging growth company - **Business address**: 47071 BAYSIDE PARKWAY, FREMONT, CA, 94538 - **Phone**: 510-626-9888 - **Shares outstanding**: 69,392,766 as of 2026-07-31 (10-Q filed 2026-08-11) ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/2104204/000119312526378360/d262303d8k.htm) filed 2026-09-01 - [10-Q](https://www.sec.gov/Archives/edgar/data/2104204/000119312526343003/ck0002104204-20260630.htm) filed 2026-08-11 - [8-K](https://www.sec.gov/Archives/edgar/data/2104204/000119312526342378/ck0002104204-20260810.htm) filed 2026-08-10 - [8-K](https://www.sec.gov/Archives/edgar/data/2104204/000119312526304736/d112405d8k.htm) filed 2026-07-15 - [10-Q](https://www.sec.gov/Archives/edgar/data/2104204/000119312526213424/ck0002104204-20260331.htm) filed 2026-05-08 - [8-K](https://www.sec.gov/Archives/edgar/data/2104204/000119312526213379/ck0002104204-20260508.htm) filed 2026-05-08 - [8-K](https://www.sec.gov/Archives/edgar/data/2104204/000119312526163921/d103481d8k.htm) filed 2026-04-20 - [S-1](https://www.sec.gov/Archives/edgar/data/2104204/000119312526129039/d39680ds1.htm) filed 2026-03-27 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002104204), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Alamar Biosciences, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ALMR, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Alamar Biosciences, Inc. - **Ticker**: ALMR - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Biotechnology - **ISIN**: US0109111056 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-ALMR/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/alamar-biosciences/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Alamar Biosciences (ALMR) news: IPO", 2026-10-31, https://aibio.space/companies/alamar-biosciences/